Stay updated on XEN1101 in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 in Focal-Onset Seizures Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew trial sites added across numerous US states and international locations, and the revision updated to v3.3.3 with a 2025-12-19 date.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. This update appears to be a backend/version bump with no visible changes to study content or layout.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the government funding lapse notice warning about potential data updates and delayed responses; core trial details, eligibility criteria, and study status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedUpdates are limited to superficial layout and wording changes on the Study Details page, with no changes to the trial design, primary outcomes, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedUpdate includes a funding/status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedIntroduces version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a scope update for the page.SummaryDifference0.3%

Stay in the know with updates to XEN1101 in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 in Focal-Onset Seizures Clinical Trial page.